GuruFocus
26 Jun 2026, 04:00 UTC · 3h ago
Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GuruFocus
26 Jun 2026, 04:00 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Nuvation Bio has priced an upsized offering of $250.0 million in convertible senior notes. — Significant capital infusion strengthens the balance sheet and extends the company's cash runway for R&D.
+0.40Which stocks this story touches
The company successfully priced and upsized a $250 million offering of convertible senior notes, indicating strong investor demand.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
10h ago
